Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Omega-3s and Phytosterols: A Promising Pair for Heart Disease Protection
Increasingly popular omega-3 fatty acids—found in sources like fish—and plant extracts known as phytosterols—which occur naturally in sources like vegetable oils, whole grains, nuts, and legumes—are known to have beneficial effects on fats (lipids) in the blood that affect heart health, such as cholesterol and triglycerides. Now a new study suggests that when taken in combination, they may have even more powerful effects.
- Cognis Puts Spotlight on Heart Health at SupplySide West
- Cognis Puts Spotlight on Heart Health at SupplySide West
- Cognis Puts Spotlight on Heart Health at SupplySide West
- New Research; Vitamin K is Required to Inhibit Calcium Accumulation in the Arteries
A new publication by Schurgers et al., titled Matrix Gla-protein: The calcification inhibitor in need of vitamin K elucidates the pivotal importance of vitamin K in the activation of Matrix Gla Protein (MGP), the most potent inhibitor of vascular calcification known.
- New Research; Vitamin K is Required to Inhibit Calcium Accumulation in the Arteries
A new publication by Schurgers et al., titled Matrix Gla-protein: The calcification inhibitor in need of vitamin K elucidates the pivotal importance of vitamin K in the activation of Matrix Gla Protein (MGP), the most potent inhibitor of vascular calcification known.
- New Research; Vitamin K is Required to Inhibit Calcium Accumulation in the Arteries
A new publication by Schurgers et al., titled Matrix Gla-protein: The calcification inhibitor in need of vitamin K elucidates the pivotal importance of vitamin K in the activation of Matrix Gla Protein (MGP), the most potent inhibitor of vascular calcification known.
- New Research; Vitamin K is Required to Inhibit Calcium Accumulation in the Arteries
A new publication by Schurgers et al., titled Matrix Gla-protein: The calcification inhibitor in need of vitamin K elucidates the pivotal importance of vitamin K in the activation of Matrix Gla Protein (MGP), the most potent inhibitor of vascular calcification known.
- New Research; Vitamin K is Required to Inhibit Calcium Accumulation in the Arteries
A new publication by Schurgers et al., titled Matrix Gla-protein: The calcification inhibitor in need of vitamin K elucidates the pivotal importance of vitamin K in the activation of Matrix Gla Protein (MGP), the most potent inhibitor of vascular calcification known.
- New Research; Vitamin K is Required to Inhibit Calcium Accumulation in the Arteries
A new publication by Schurgers et al., titled Matrix Gla-protein: The calcification inhibitor in need of vitamin K elucidates the pivotal importance of vitamin K in the activation of Matrix Gla Protein (MGP), the most potent inhibitor of vascular calcification known.
- Want to Help Your Heart? Get a Good Night's Sleep
- Want to Help Your Heart? Get a Good Night's Sleep
- Want to Help Your Heart? Get a Good Night's Sleep
- Want to Help Your Heart? Get a Good Night's Sleep
- Want to Help Your Heart? Get a Good Night's Sleep
- Want to Help Your Heart? Get a Good Night's Sleep
- Want to Help Your Heart? Get a Good Night's Sleep
- Want to Help Your Heart? Get a Good Night's Sleep
- Review Identifies Dietary Factors Associated with Heart Disease Risk
A review of previously published studies suggests that vegetable and nut intake and a Mediterranean dietary pattern appear to be associated with a lower risk for heart disease, according to a report published in the April 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. However, intake of trans-fatty acids and foods with a high glycemic index may be harmful to heart health.
- Review Identifies Dietary Factors Associated with Heart Disease Risk
A review of previously published studies suggests that vegetable and nut intake and a Mediterranean dietary pattern appear to be associated with a lower risk for heart disease, according to a report published in the April 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. However, intake of trans-fatty acids and foods with a high glycemic index may be harmful to heart health.
- Review Identifies Dietary Factors Associated with Heart Disease Risk
A review of previously published studies suggests that vegetable and nut intake and a Mediterranean dietary pattern appear to be associated with a lower risk for heart disease, according to a report published in the April 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. However, intake of trans-fatty acids and foods with a high glycemic index may be harmful to heart health.
- Review Identifies Dietary Factors Associated with Heart Disease Risk
A review of previously published studies suggests that vegetable and nut intake and a Mediterranean dietary pattern appear to be associated with a lower risk for heart disease, according to a report published in the April 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. However, intake of trans-fatty acids and foods with a high glycemic index may be harmful to heart health.
- Review Identifies Dietary Factors Associated with Heart Disease Risk
A review of previously published studies suggests that vegetable and nut intake and a Mediterranean dietary pattern appear to be associated with a lower risk for heart disease, according to a report published in the April 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. However, intake of trans-fatty acids and foods with a high glycemic index may be harmful to heart health.
- Review Identifies Dietary Factors Associated with Heart Disease Risk
A review of previously published studies suggests that vegetable and nut intake and a Mediterranean dietary pattern appear to be associated with a lower risk for heart disease, according to a report published in the April 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. However, intake of trans-fatty acids and foods with a high glycemic index may be harmful to heart health.
- Review Identifies Dietary Factors Associated with Heart Disease Risk
A review of previously published studies suggests that vegetable and nut intake and a Mediterranean dietary pattern appear to be associated with a lower risk for heart disease, according to a report published in the April 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. However, intake of trans-fatty acids and foods with a high glycemic index may be harmful to heart health.
- Review Identifies Dietary Factors Associated with Heart Disease Risk
A review of previously published studies suggests that vegetable and nut intake and a Mediterranean dietary pattern appear to be associated with a lower risk for heart disease, according to a report published in the April 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. However, intake of trans-fatty acids and foods with a high glycemic index may be harmful to heart health.
- Walnuts and Fish Protect Against Heart Disease in Different Ways, According to Newly Published Research
Loma Linda University has published new research in the American Journal of Clinical Nutrition which compares the effects of walnuts and fatty fish in the fight against heart disease, demonstrating that in healthy individuals, walnuts lower cholesterol more than fish, while fatty fish lower triglycerides. Both can reduce the overall risk of coronary heart disease.
- Walnuts and Fish Protect Against Heart Disease in Different Ways, According to Newly Published Research
Loma Linda University has published new research in the American Journal of Clinical Nutrition which compares the effects of walnuts and fatty fish in the fight against heart disease, demonstrating that in healthy individuals, walnuts lower cholesterol more than fish, while fatty fish lower triglycerides. Both can reduce the overall risk of coronary heart disease.
- Walnuts and Fish Protect Against Heart Disease in Different Ways, According to Newly Published Research
Loma Linda University has published new research in the American Journal of Clinical Nutrition which compares the effects of walnuts and fatty fish in the fight against heart disease, demonstrating that in healthy individuals, walnuts lower cholesterol more than fish, while fatty fish lower triglycerides. Both can reduce the overall risk of coronary heart disease.
- Walnuts and Fish Protect Against Heart Disease in Different Ways, According to Newly Published Research
Loma Linda University has published new research in the American Journal of Clinical Nutrition which compares the effects of walnuts and fatty fish in the fight against heart disease, demonstrating that in healthy individuals, walnuts lower cholesterol more than fish, while fatty fish lower triglycerides. Both can reduce the overall risk of coronary heart disease.
- Walnuts and Fish Protect Against Heart Disease in Different Ways, According to Newly Published Research
Loma Linda University has published new research in the American Journal of Clinical Nutrition which compares the effects of walnuts and fatty fish in the fight against heart disease, demonstrating that in healthy individuals, walnuts lower cholesterol more than fish, while fatty fish lower triglycerides. Both can reduce the overall risk of coronary heart disease.
- Walnuts and Fish Protect Against Heart Disease in Different Ways, According to Newly Published Research
Loma Linda University has published new research in the American Journal of Clinical Nutrition which compares the effects of walnuts and fatty fish in the fight against heart disease, demonstrating that in healthy individuals, walnuts lower cholesterol more than fish, while fatty fish lower triglycerides. Both can reduce the overall risk of coronary heart disease.
- Walnuts and Fish Protect Against Heart Disease in Different Ways, According to Newly Published Research
Loma Linda University has published new research in the American Journal of Clinical Nutrition which compares the effects of walnuts and fatty fish in the fight against heart disease, demonstrating that in healthy individuals, walnuts lower cholesterol more than fish, while fatty fish lower triglycerides. Both can reduce the overall risk of coronary heart disease.
- Walnuts and Fish Protect Against Heart Disease in Different Ways, According to Newly Published Research
Loma Linda University has published new research in the American Journal of Clinical Nutrition which compares the effects of walnuts and fatty fish in the fight against heart disease, demonstrating that in healthy individuals, walnuts lower cholesterol more than fish, while fatty fish lower triglycerides. Both can reduce the overall risk of coronary heart disease.
- Walnuts and Fish Protect Against Heart Disease in Different Ways, According to Newly Published Research
Loma Linda University has published new research in the American Journal of Clinical Nutrition which compares the effects of walnuts and fatty fish in the fight against heart disease, demonstrating that in healthy individuals, walnuts lower cholesterol more than fish, while fatty fish lower triglycerides. Both can reduce the overall risk of coronary heart disease.
- New Preclinical Study in Rats Examines Superba Krill Oil Versus Fish Oil for Reduction of Fat in Heart and Liver
A study published in the Journal of Nutrition, Volume 139, Number 8, August 2009, follows a rat preclinical study performed for the biotechnological company Aker BioMarine, and examines the reduction of fat in the heart and the liver comparing Superba Krill Oil and omega-3 from fish oil.
- New Preclinical Study in Rats Examines Superba Krill Oil Versus Fish Oil for Reduction of Fat in Heart and Liver
A study published in the Journal of Nutrition, Volume 139, Number 8, August 2009, follows a rat preclinical study performed for the biotechnological company Aker BioMarine, and examines the reduction of fat in the heart and the liver comparing Superba Krill Oil and omega-3 from fish oil.
- New Preclinical Study in Rats Examines Superba Krill Oil Versus Fish Oil for Reduction of Fat in Heart and Liver
A study published in the Journal of Nutrition, Volume 139, Number 8, August 2009, follows a rat preclinical study performed for the biotechnological company Aker BioMarine, and examines the reduction of fat in the heart and the liver comparing Superba Krill Oil and omega-3 from fish oil.
- New Preclinical Study in Rats Examines Superba Krill Oil Versus Fish Oil for Reduction of Fat in Heart and Liver
A study published in the Journal of Nutrition, Volume 139, Number 8, August 2009, follows a rat preclinical study performed for the biotechnological company Aker BioMarine, and examines the reduction of fat in the heart and the liver comparing Superba Krill Oil and omega-3 from fish oil.
- New Preclinical Study in Rats Examines Superba Krill Oil Versus Fish Oil for Reduction of Fat in Heart and Liver
A study published in the Journal of Nutrition, Volume 139, Number 8, August 2009, follows a rat preclinical study performed for the biotechnological company Aker BioMarine, and examines the reduction of fat in the heart and the liver comparing Superba Krill Oil and omega-3 from fish oil.
- DSM Nutritional Products Announces First Human Data on resVida(R) Trans-resveratrol Which Demonstrates Potential Cardiovascular Health Benefits
Data from two analyses of the first human study of resVida(R) trans-resveratrol that were presented at the 4th International Conference on Polyphenols and Health (ICPH) in Yorkshire, England, Dec. 7-10, 2009 and the Nutrition Society of Australia (NSA) and Nutrition Society of New Zealand (NSNZ) Joint Annual Scientific Meeting in Newcastle, NSW, Dec. 8-11, 2009. The data showed resVida(R) is the first pure trans-resveratrol dietary ingredient to demonstrate cardiovascular health benefits in humans.
- DSM Nutritional Products Announces First Human Data on resVida(R) Trans-resveratrol Which Demonstrates Potential Cardiovascular Health Benefits
Data from two analyses of the first human study of resVida(R) trans-resveratrol that were presented at the 4th International Conference on Polyphenols and Health (ICPH) in Yorkshire, England, Dec. 7-10, 2009 and the Nutrition Society of Australia (NSA) and Nutrition Society of New Zealand (NSNZ) Joint Annual Scientific Meeting in Newcastle, NSW, Dec. 8-11, 2009. The data showed resVida(R) is the first pure trans-resveratrol dietary ingredient to demonstrate cardiovascular health benefits in humans.
- DSM Nutritional Products Announces First Human Data on resVida(R) Trans-resveratrol Which Demonstrates Potential Cardiovascular Health Benefits
Data from two analyses of the first human study of resVida(R) trans-resveratrol that were presented at the 4th International Conference on Polyphenols and Health (ICPH) in Yorkshire, England, Dec. 7-10, 2009 and the Nutrition Society of Australia (NSA) and Nutrition Society of New Zealand (NSNZ) Joint Annual Scientific Meeting in Newcastle, NSW, Dec. 8-11, 2009. The data showed resVida(R) is the first pure trans-resveratrol dietary ingredient to demonstrate cardiovascular health benefits in humans.
- DSM Nutritional Products Announces First Human Data on resVida(R) Trans-resveratrol Which Demonstrates Potential Cardiovascular Health Benefits
Data from two analyses of the first human study of resVida(R) trans-resveratrol that were presented at the 4th International Conference on Polyphenols and Health (ICPH) in Yorkshire, England, Dec. 7-10, 2009 and the Nutrition Society of Australia (NSA) and Nutrition Society of New Zealand (NSNZ) Joint Annual Scientific Meeting in Newcastle, NSW, Dec. 8-11, 2009. The data showed resVida(R) is the first pure trans-resveratrol dietary ingredient to demonstrate cardiovascular health benefits in humans.
- DSM Nutritional Products Announces First Human Data on resVida(R) Trans-resveratrol Which Demonstrates Potential Cardiovascular Health Benefits
Data from two analyses of the first human study of resVida(R) trans-resveratrol that were presented at the 4th International Conference on Polyphenols and Health (ICPH) in Yorkshire, England, Dec. 7-10, 2009 and the Nutrition Society of Australia (NSA) and Nutrition Society of New Zealand (NSNZ) Joint Annual Scientific Meeting in Newcastle, NSW, Dec. 8-11, 2009. The data showed resVida(R) is the first pure trans-resveratrol dietary ingredient to demonstrate cardiovascular health benefits in humans.
- DSM Nutritional Products Announces First Human Data on resVida(R) Trans-resveratrol Which Demonstrates Potential Cardiovascular Health Benefits
Data from two analyses of the first human study of resVida(R) trans-resveratrol that were presented at the 4th International Conference on Polyphenols and Health (ICPH) in Yorkshire, England, Dec. 7-10, 2009 and the Nutrition Society of Australia (NSA) and Nutrition Society of New Zealand (NSNZ) Joint Annual Scientific Meeting in Newcastle, NSW, Dec. 8-11, 2009. The data showed resVida(R) is the first pure trans-resveratrol dietary ingredient to demonstrate cardiovascular health benefits in humans.
- DSM Nutritional Products Announces First Human Data on resVida(R) Trans-resveratrol Which Demonstrates Potential Cardiovascular Health Benefits
Data from two analyses of the first human study of resVida(R) trans-resveratrol that were presented at the 4th International Conference on Polyphenols and Health (ICPH) in Yorkshire, England, Dec. 7-10, 2009 and the Nutrition Society of Australia (NSA) and Nutrition Society of New Zealand (NSNZ) Joint Annual Scientific Meeting in Newcastle, NSW, Dec. 8-11, 2009. The data showed resVida(R) is the first pure trans-resveratrol dietary ingredient to demonstrate cardiovascular health benefits in humans.
- DSM Nutritional Products Announces First Human Data on resVida(R) Trans-resveratrol Which Demonstrates Potential Cardiovascular Health Benefits
Data from two analyses of the first human study of resVida(R) trans-resveratrol that were presented at the 4th International Conference on Polyphenols and Health (ICPH) in Yorkshire, England, Dec. 7-10, 2009 and the Nutrition Society of Australia (NSA) and Nutrition Society of New Zealand (NSNZ) Joint Annual Scientific Meeting in Newcastle, NSW, Dec. 8-11, 2009. The data showed resVida(R) is the first pure trans-resveratrol dietary ingredient to demonstrate cardiovascular health benefits in humans.
- Fuji Grows Cardiovascular Body of Science for Astaxanthin
A new human clinical study conducted at Jikei University, Japan reports that supplementation at a dose of 12mg per day this randomized, placebo-controlled study showed a significant decrease in blood serum triglyceride and increase in HDL-cholesterol levels with a corresponding increase in serum adiponectin, independent of age and BMI.
- Fuji Grows Cardiovascular Body of Science for Astaxanthin
A new human clinical study conducted at Jikei University, Japan reports that supplementation at a dose of 12mg per day this randomized, placebo-controlled study showed a significant decrease in blood serum triglyceride and increase in HDL-cholesterol levels with a corresponding increase in serum adiponectin, independent of age and BMI.
- Fuji Grows Cardiovascular Body of Science for Astaxanthin
A new human clinical study conducted at Jikei University, Japan reports that supplementation at a dose of 12mg per day this randomized, placebo-controlled study showed a significant decrease in blood serum triglyceride and increase in HDL-cholesterol levels with a corresponding increase in serum adiponectin, independent of age and BMI.
- Fuji Grows Cardiovascular Body of Science for Astaxanthin
A new human clinical study conducted at Jikei University, Japan reports that supplementation at a dose of 12mg per day this randomized, placebo-controlled study showed a significant decrease in blood serum triglyceride and increase in HDL-cholesterol levels with a corresponding increase in serum adiponectin, independent of age and BMI.
- Fuji Grows Cardiovascular Body of Science for Astaxanthin
A new human clinical study conducted at Jikei University, Japan reports that supplementation at a dose of 12mg per day this randomized, placebo-controlled study showed a significant decrease in blood serum triglyceride and increase in HDL-cholesterol levels with a corresponding increase in serum adiponectin, independent of age and BMI.
- Study reveals how one form of natural vitamin E protects brain after stroke
In a study using mouse brain cells, scientists found that the tocotrienol form of vitamin E stopped an enzyme from releasing fatty acids that eventually kill neurons.
- Study reveals how one form of natural vitamin E protects brain after stroke
In a study using mouse brain cells, scientists found that the tocotrienol form of vitamin E stopped an enzyme from releasing fatty acids that eventually kill neurons.
- Study reveals how one form of natural vitamin E protects brain after stroke
In a study using mouse brain cells, scientists found that the tocotrienol form of vitamin E stopped an enzyme from releasing fatty acids that eventually kill neurons.
- Study reveals how one form of natural vitamin E protects brain after stroke
In a study using mouse brain cells, scientists found that the tocotrienol form of vitamin E stopped an enzyme from releasing fatty acids that eventually kill neurons.
- Study reveals how one form of natural vitamin E protects brain after stroke
In a study using mouse brain cells, scientists found that the tocotrienol form of vitamin E stopped an enzyme from releasing fatty acids that eventually kill neurons.
- Study reveals how one form of natural vitamin E protects brain after stroke
In a study using mouse brain cells, scientists found that the tocotrienol form of vitamin E stopped an enzyme from releasing fatty acids that eventually kill neurons.
- Study reveals how one form of natural vitamin E protects brain after stroke
In a study using mouse brain cells, scientists found that the tocotrienol form of vitamin E stopped an enzyme from releasing fatty acids that eventually kill neurons.
- Study reveals how one form of natural vitamin E protects brain after stroke
In a study using mouse brain cells, scientists found that the tocotrienol form of vitamin E stopped an enzyme from releasing fatty acids that eventually kill neurons.
- Study reveals how one form of natural vitamin E protects brain after stroke
In a study using mouse brain cells, scientists found that the tocotrienol form of vitamin E stopped an enzyme from releasing fatty acids that eventually kill neurons.
- Research Published by Standard Process Inc. Scientists About the Effects of Dietary Intervention on Cholesterol Levels
In collaboration with the scientists in the Department of Animal Sciences at the University of Wisconsin-Madison, Standard Process scientists have published a study examining the effects of nutritional supplement ingredients on cholesterol levels in Rapacz familial hypercholesterolemic swine or FH swine. Findings of this study were reported in the Journal of Medicinal Food.
- Research Published by Standard Process Inc. Scientists About the Effects of Dietary Intervention on Cholesterol Levels
In collaboration with the scientists in the Department of Animal Sciences at the University of Wisconsin-Madison, Standard Process scientists have published a study examining the effects of nutritional supplement ingredients on cholesterol levels in Rapacz familial hypercholesterolemic swine or FH swine. Findings of this study were reported in the Journal of Medicinal Food.
- Research Published by Standard Process Inc. Scientists About the Effects of Dietary Intervention on Cholesterol Levels
In collaboration with the scientists in the Department of Animal Sciences at the University of Wisconsin-Madison, Standard Process scientists have published a study examining the effects of nutritional supplement ingredients on cholesterol levels in Rapacz familial hypercholesterolemic swine or FH swine. Findings of this study were reported in the Journal of Medicinal Food.
- Research Published by Standard Process Inc. Scientists About the Effects of Dietary Intervention on Cholesterol Levels
In collaboration with the scientists in the Department of Animal Sciences at the University of Wisconsin-Madison, Standard Process scientists have published a study examining the effects of nutritional supplement ingredients on cholesterol levels in Rapacz familial hypercholesterolemic swine or FH swine. Findings of this study were reported in the Journal of Medicinal Food.
- Research Published by Standard Process Inc. Scientists About the Effects of Dietary Intervention on Cholesterol Levels
In collaboration with the scientists in the Department of Animal Sciences at the University of Wisconsin-Madison, Standard Process scientists have published a study examining the effects of nutritional supplement ingredients on cholesterol levels in Rapacz familial hypercholesterolemic swine or FH swine. Findings of this study were reported in the Journal of Medicinal Food.
- Research Published by Standard Process Inc. Scientists About the Effects of Dietary Intervention on Cholesterol Levels
In collaboration with the scientists in the Department of Animal Sciences at the University of Wisconsin-Madison, Standard Process scientists have published a study examining the effects of nutritional supplement ingredients on cholesterol levels in Rapacz familial hypercholesterolemic swine or FH swine. Findings of this study were reported in the Journal of Medicinal Food.
- Pilot Clinical Trial on Sambazon Acai
A new pilot clinical trial investigating the health benefits of acai was presented at the Scripps Center for Integrative Medicine on January 23 and revealed promising initial results for vascular health.
- Pilot Clinical Trial on Sambazon Acai
A new pilot clinical trial investigating the health benefits of acai was presented at the Scripps Center for Integrative Medicine on January 23 and revealed promising initial results for vascular health.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- New Company for “Change-The-World” Entrepreneurs™ Launches
- GMP Labs Expands Liquid Nutraceutical Capabilities
- What Parents Should Know About Kids and Supplements
- What Parents Should Know About Kids and Supplements
- Oats Beat Back Cholesterol
- Oats Beat Back Cholesterol
- Seniors: Pump Up for Strong Bones and Heart
- Seniors: Pump Up for Strong Bones and Heart
|
A new study shows a vegetarian version of the Atkins low-carbohydrate diet may help people lose weight and lower levels of bad (or, LDL) cholesterol in the blood. The traditional Atkins diet consists of low carbohydrate foods and a high intake of animal protein. Although studies to date have shown the traditional Atkins diet may produce modest weight loss, these studies have not demonstrated a reduction in the major heart disease risk factor, LDL or "bad" cholesterol levels.
Researchers from St. Michael's Hospital and the University of Toronto in collaboration with researchers from Solae LLC, a leader in soy protein innovation and technology, published the first ever study to look at the effect of a modified version of the Atkins diet on both weight loss and heart disease risk factors. The study, which is published in the current issue of the Archives of Internal Medicine, looked at weight loss and heart disease risk factors of subjects who followed a diet low in carbohydrates, but high in vegetable proteins that included soy.
Forty-seven overweight men and women with elevated blood cholesterol and triglyceride levels were given either a low carbohydrate diet where the protein came from vegetable sources including soy, or a high carbohydrate, low-fat, lacto-ovo vegetarian diet for four weeks. Calorie restriction was similar for both groups. There was similar weight loss and lowered blood pressure in both groups; however, the low carbohydrate, higher protein diet group also saw significant reductions in LDL cholesterol and other heart disease risk factors like apolipoproteins, blood triglyceride levels and blood pressure.
Results showed that participants who ate a low-calorie, low-carbohydrate diet high in plant-based proteins, oils and fiber, lost weight and experienced improvements in blood cholesterol levels and other heart disease risk factors. These findings suggest that an eco-friendly version of the Atkins weight-loss diet -- stressing plant proteins -- is better than a high carbohydrate weight-loss diet at reducing risk factors of heart disease.
"Our study demonstrated that when a low carbohydrate diet was given using plant foods rather than the more usual animal proteins and fats, advantages were seen in cholesterol and blood pressure reduction," said Dr. David J. A. Jenkins. "Soy proteins and nuts were valuable sources of protein and nuts also provided healthy oils. These foods have individually been associated with cholesterol reduction in other studies."
Numerous studies show that soy intakes may be associated with a lower incidence of certain chronic diseases, notably heart disease. These findings led to the authorization of a health claim for soy protein and heart disease risk by the Food & Drug Administration (FDA) in 1999. The FDA-authorized health claim helps promote the daily consumption of 25 grams of soy for lowering cholesterol levels and reducing the risk of heart disease.
"While total calories are important for weight loss, a plant-based diet that includes soy, instead of animal-based provides additional benefits that may reduce the risk of heart disease," said Dr. Greg Paul, sports nutrition expert at Solae and an author of the study. "These findings build on the body of evidence for the role of soy protein in lowering heart disease risk."
This study further confirms the heart health benefits of soy protein. Research continues to show that consuming 25 grams of soy protein per day results in significant and meaningful reductions in total cholesterol and LDL cholesterol. Soy-based foods can easily be a part of a healthy, low-cholesterol, low-fat diet that includes a variety of products, such as nutritional bars, beverages, veggie burgers, cereal, and more, to make eating heart healthy convenient for consumers.
Solae LLC is the world leader in developing innovative soy-based technology and ingredients for food and nutritional products. Solae provides solutions that deliver a unique combination of functional, nutritional and economic benefits to our customers. At Solae, we take one of nature's best resources, the soybean, and create nutritious and great-tasting ingredients. Our goal is to provide solutions for today while innovating for tomorrow. With more than 1,000 products used by more than 3,500 customers, Solae's soy ingredients are enjoyed by consumers around the world in products such as baked goods, beverages, nutrition bars, meats, vegetarian meals and much more. Headquartered in St. Louis, Missouri, USA, with annual revenue exceeding $1 billion, the company was formed through an alliance between Bunge Limited and DuPont. For more information, visit www.solae.com. |